You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 24, 2024

CLINICAL TRIALS PROFILE FOR BRODALUMAB

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for brodalumab

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01708590 ↗	Efficacy, Safety, and Withdrawal and Retreatment With Brodalumab in Moderate to Severe Plaque Psoriasis Subjects	Terminated	Amgen	Phase 3	2012-08-01	The purpose of this study is to assess the safety and efficacy of brodalumab taken every two weeks at two different doses.
NCT01708590 ↗	Efficacy, Safety, and Withdrawal and Retreatment With Brodalumab in Moderate to Severe Plaque Psoriasis Subjects	Terminated	Bausch Health Americas, Inc.	Phase 3	2012-08-01	The purpose of this study is to assess the safety and efficacy of brodalumab taken every two weeks at two different doses.
NCT01708603 ↗	P3 Study Brodalumab in Treatment of Moderate to Severe Plaque Psoriasis	Terminated	Amgen	Phase 3	2012-08-01	The purpose of this study is to assess the safety and efficacy of brodalumab at two different doses
NCT01708603 ↗	P3 Study Brodalumab in Treatment of Moderate to Severe Plaque Psoriasis	Terminated	Bausch Health Americas, Inc.	Phase 3	2012-08-01	The purpose of this study is to assess the safety and efficacy of brodalumab at two different doses
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for brodalumab

Condition Name

Chart
Table

Condition Name for brodalumab
Intervention	Trials
Psoriasis	8
Moderate to Severe Plaque Psoriasis	5
Hidradenitis Suppurativa	4
Psoriasis Vulgaris	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for brodalumab
Intervention	Trials
Psoriasis	14
Hidradenitis Suppurativa	4
Hidradenitis	4
Arthritis, Psoriatic	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for brodalumab

Trials by Country

Map
Table

Trials by Country for brodalumab
Location	Trials
United States	133
Canada	33
Spain	14
Australia	11
Mexico	10
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for brodalumab
Location	Trials
New York	9
Texas	8
Florida	7
California	7
Arizona	6
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for brodalumab

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for brodalumab
Clinical Trial Phase	Trials
Phase 4	6
Phase 3	8
Phase 2	2
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for brodalumab
Clinical Trial Phase	Trials
Completed	9
Terminated	4
Withdrawn	3
[disabled in preview]	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for brodalumab

Sponsor Name

Chart
Table

Sponsor Name for brodalumab
Sponsor	Trials
Amgen	8
Bausch Health Americas, Inc.	8
Kyowa Kirin Co., Ltd.	3
[disabled in preview]	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for brodalumab
Sponsor	Trials
Industry	28
Other	10
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.